Gene: PALD1
Official Full Name: phosphatase domain containing paladin 1provided by HGNC
Gene Summary: Predicted to enable protein tyrosine phosphatase activity. Located in cytosol. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO27799 | PALD1 Knockout cell line (HCT 116) | Human | PALD1 | 1:2~1:4 | Negative | Online Inquiry |
KO27800 | PALD1 Knockout cell line (HEK293) | Human | PALD1 | 1:3~1:6 | Negative | Online Inquiry |
KO27801 | PALD1 Knockout cell line (A549) | Human | PALD1 | 1:3~1:4 | Negative | Online Inquiry |
PALD1 Gene Knockout Cell Lines are genetically modified cell lines in which the PALD1 gene has been selectively disrupted, allowing researchers to investigate the role of this gene in cellular processes such as adhesion, migration, and signaling. By manipulating the expression of PALD1, scientists can elucidate its contributions to various pathological conditions, including cancer and developmental disorders. This model is particularly vital for exploring the biological mechanisms underlying these diseases, providing significant insights that could inform therapeutic strategies.
The PALD1 gene encodes a cytoplasmic protein implicated in cell motility and cytoskeletal dynamics. Deletion of PALD1 impacts the interaction of cells with their extracellular matrix and neighboring cells, which can elucidate the pathway dynamics involved in tumor progression and metastasis. By utilizing these knockout cell lines, researchers can observe changes in phenotypic behaviors, gene expression profiles, and signaling cascades that might otherwise remain obscured.
The scientific significance of PALD1 Gene Knockout Cell Lines extends to their utility in drug discovery and precision medicine, allowing for the screening of potential therapeutics that target specific pathways influenced by PALD1. Compared to conventional wild-type cell lines, these knockout models offer a unique perspective that reveals the consequences of gene loss in a controlled environment, fostering reproducibility and clarity in experimental outcomes.
Researchers and clinicians will find value in these cell lines due to their potential for uncovering new therapeutic targets and understanding disease mechanisms. Moreover, PALD1 Gene Knockout Cell Lines contribute to the advancement of genomic research, making them indispensable tools in modern biology.
Our company specializes in the provision of advanced genetic models and tools, ensuring researchers have access to high-quality products that support innovative research endeavors. The expertise and reliability of our offerings foster scientific discoveries that can lead to meaningful advancements in healthcare and treatment modalities.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.